Sign In
Buy MRK
$113.87
-1.62 (-1.40%)
At Close: Jun 18, 2026
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
05:12pm, Monday, 17'th Jun 2024
The Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and a lung infection called pneumonia. An ad
Merck's vaccine approval poses threat to one of Pfizer's top-selling products
05:06pm, Monday, 17'th Jun 2024
Merck & Co. Inc. on Monday gained U.S. regulatory approval for a vaccine that could become a tough competitor to one of Pfizer Inc.'s top-selling products.
Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade
06:50pm, Wednesday, 12'th Jun 2024
In the closing of the recent trading day, Merck (MRK) stood at $130.20, denoting a -1.24% change from the preceding trading day.
Merck & Co., Inc. (MRK) Goldman Sachs 45th Annual Global Healthcare Conference - (Transcript)
12:34pm, Tuesday, 11'th Jun 2024
Merck & Co., Inc. (NYSE:MRK ) Goldman Sachs 45th Annual Global Healthcare Conference Call June 11, 2024 10:00 AM ET Company Participants Robert Davis - Chairman, President and Chief Executive Officer
Merck looks for next-generation opportunities in obesity
10:53am, Tuesday, 11'th Jun 2024
Merck is focused on second and third-generation opportunities in the cardiometabolic drugs market, which includes treatments for obesity, the drugmaker said at a healthcare conference on Tuesday.
3 High-Yield Dividend Stocks to Collect Impressive Payouts Year After Year
07:00am, Tuesday, 11'th Jun 2024
High-yield dividend stocks typically distribute a significant portion of their profits back to shareholders in the form ofdividends. In addition to regular dividend income, such shares offer the p
Dividends And Innovation: Why Merck Is A Healthcare Stock Worth Buying
10:23am, Monday, 10'th Jun 2024
Merck's Keytruda drug has shown promising results in treating bowel cancer, according to Germany's largest newspaper. Merck has significantly increased its oncology portfolio, with Keytruda achieving
Final Trades: Nike, Merck, General Motors and the XLE
01:26pm, Friday, 07'th Jun 2024
The Investment Committee give you their top stocks to watch for the second half.
2 Dividend Stocks Billionaires Are Buying: Should You?
09:30am, Friday, 07'th Jun 2024
Several notable billionaire hedge fund managers have bought shares of Pfizer or Merck recently. Despite immediate or upcoming headwinds, both companies look like strong picks for income investors.
Merck Completes € 180 Million Investment to Expand Schnelldorf Distribution Center
04:00am, Thursday, 06'th Jun 2024
DARMSTADT, Germany--(BUSINESS WIRE)--Merck opened its expanded Life Science distribution center in Schnelldorf, Germany. The € 180 investment added 25,000 square meters to the site.
Merck (MRK) Ascends But Remains Behind Market: Some Facts to Note
06:46pm, Wednesday, 05'th Jun 2024
The latest trading day saw Merck (MRK) settling at $129.45, representing a +0.57% change from its previous close.
Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
06:45am, Wednesday, 05'th Jun 2024
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference.
Merck & Co., Inc. (MRK) Investor Event at ASCO 2024 (Transcript)
01:31pm, Tuesday, 04'th Jun 2024
Merck & Co., Inc. (NYSE:MRK ) Investor Event at ASCO 2024 June 3, 2024 7:00 PM ET Company Participants Peter Dannenbaum - Senior Vice President, Investor Relations Dean Li - President of Merck Researc
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
11:12am, Tuesday, 04'th Jun 2024
Cancer vaccines are finally showing promise as Moderna and Merck touted promising data on an experimental skin cancer vaccine and the U.K. announced plans for a “landmark” scheme to test the techn
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
09:00am, Monday, 03'rd Jun 2024
Moderna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study in patients with a deadly form of skin canc
